BioAge Labs logo

BioAge Labs

We are harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases.

99 employees · est. 2015 · Emeryville, United States

VS
Khloris Biosciences logo

Khloris Biosciences

Pioneering medical treatment using advanced stem cell technology to address critical cardiovascular and other diseases with significant unmet needs.

est. 2017

BioAge Labs is the older company (2015 vs 2017).

Side-by-Side Comparison

BioAge Labs Khloris Biosciences
Founded
2015 older 2017
Headquarters
Emeryville, United States Not tracked yet
Employees
99 Not tracked yet
Industry
Biopharma, Biotechnology, Health and Wellness Biotechnology, Life Sciences, Pharmaceutical
Funding Stage
Series D Series Unknown
Total Funding
$293.90M $5.00M
Funding Rounds
4 1
Services
Development of therapies for metabolic diseases, Research on NLRP3 inhibitors, Development of APJ agonists for weight loss, Multi-omics data analysis for aging research Not tracked yet
Target Customers
Pharmaceutical companies, Biotech investors, Healthcare providers, Patients with metabolic diseases Not tracked yet
Taxonomy
Biopharmaceutical, Metabolic Diseases, Human Aging Biology, NLRP3 Inhibitor, Cardiovascular Risk, Retinal Diseases, Preclinical Programs, Drug Discovery, Longevity Data, APJ Agonists, Obesity Treatment, Brain-penetrant Small Molecules, Aging-related Diseases, Clinical-stage Development Stem Cell Technology, Cardiovascular Diseases, Drug Screening, Induced Pluripotent Stem Cells, Medical Innovation, Bay Area, Biomedical Research, Disease-Specific Treatment, Unmet Medical Needs, Innovative Therapies
Website
bioagelabs.com khlorisbiosciences.com
BioAge Labs logo

About BioAge Labs

BioAge Labs, founded in 2015, stands at the forefront of the biopharmaceutical industry, leveraging the biology of human aging to devise novel therapeutic targets for metabolic diseases. Positioned in the United States, this clinical-stage company is actively developing therapeutic product candidate...

Khloris Biosciences logo

About Khloris Biosciences

Khloris Biosciences is a biotechnology startup based in the Bay Area that was established in 2017. The company is dedicated to advancing the treatment of cardiovascular and other diseases with significant unmet needs. Their groundbreaking approach involves using disease-specific induced pluripotent...

We will tell you when either one moves

BounceWatch watches BioAge Labs and Khloris Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at BioAge Labs and Khloris Biosciences — by email.

Frequently Asked Questions

BioAge Labs — We are harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases.. Khloris Biosciences — Pioneering medical treatment using advanced stem cell technology to address critical cardiovascular and other diseases with significant unmet needs.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BioAge Labs has raised $293.90M while Khloris Biosciences has raised $5.00M.
BioAge Labs and Khloris Biosciences operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BioAge Labs with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at BioAge Labs on 9 Jun 2026, and Khloris Biosciences on 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy